Next Article in Journal
Hsp90 Inhibitors in Oncology: Ready for Prime Time?
Previous Article in Journal
Design and Implementation of a Community-Based Exercise Program for Breast Cancer Patients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 5
10.3747/co.21.2023
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014

by
B. Melosky
* and
C. Ho
BC Cancer Agency–Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(5), 272-273; https://doi.org/10.3747/co.21.2023
Submission received: 2 July 2014 / Revised: 3 August 2014 / Accepted: 4 September 2014 / Published: 1 October 2014

Abstract

The Canadian Lung Cancer Conference 2014, held in Vancouver, British Columbia, was an opportunity for Canadian lung cancer researchers and treatment experts to meet and discuss current breakthroughs and paradigm shifts in the field. The full-day program featured lectures, discussion, and debates, with ample time for informal networking. We are already looking forward to next year’s meeting (scheduled for February 6, 2015), where we expect to discuss and reflect on some of the latest results and breakthroughs from both the American Society of Clinical Oncology and the European Society for Medical Oncology.
Keywords: lung cancer conferences; biomarker testing; targeted therapies; individualized therapies; quality measures lung cancer conferences; biomarker testing; targeted therapies; individualized therapies; quality measures

Share and Cite

MDPI and ACS Style

Melosky, B.; Ho, C. Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014. Curr. Oncol. 2014, 21, 272-273. https://doi.org/10.3747/co.21.2023

AMA Style

Melosky B, Ho C. Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014. Current Oncology. 2014; 21(5):272-273. https://doi.org/10.3747/co.21.2023

Chicago/Turabian Style

Melosky, B., and C. Ho. 2014. "Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014" Current Oncology 21, no. 5: 272-273. https://doi.org/10.3747/co.21.2023

APA Style

Melosky, B., & Ho, C. (2014). Optimism About Breakthroughs in the Age of Targeted Therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014. Current Oncology, 21(5), 272-273. https://doi.org/10.3747/co.21.2023

Article Metrics

Back to TopTop